Duke University leads clinical trials for various cancers.
NCI National Clinical Trials Network (UG1)
This study is working to make cancer clinical trials better and more accessible for everyone, especially for those from diverse backgrounds and with rare tumors, so that more patients can participate and benefit from new treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10799586 on NIH RePORTER |
What this research studies
This research focuses on enhancing the infrastructure and leadership for clinical trials at the Duke Cancer Institute. It aims to support the development and execution of multi-center, late-phase clinical treatment trials and imaging trials for a wide range of cancers. The initiative emphasizes participation from diverse patient populations, including underserved groups and those with rare tumors. By collaborating with multiple NCI-funded networks, the project seeks to improve patient enrollment and trial outcomes.
Who could benefit from this research
Good fit: Ideal candidates include adults, adolescents, and young adults diagnosed with various types of cancer, particularly those from underserved populations.
Not a fit: Patients with non-malignant conditions or those outside the age range of 21 years and older may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments and improved access to clinical trials for patients.
How similar studies have performed: Previous research has shown success in similar multi-center clinical trial approaches, indicating a strong potential for impactful outcomes.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Thomas, Alexandra — Duke University
- Study coordinator: Thomas, Alexandra
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.